Compare Johnson Controls International PLC (JCI) vs Novartis AG (NVS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson Controls International PLC vs Novartis AG — how do they compare? Johnson Controls International PLC trades at $140 (market cap $85.03B), while Novartis AG trades at $153.88 (market cap $290.25B). The key difference: Novartis AG is far larger — about 3.4× Johnson Controls International PLC's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| JCI | NVS | |
|---|---|---|
Market Cap | $85.03B | $290.25B |
Sector | Industrials | Health |
52-Week High | $148.21 | $168.62 |
52-Week Low | $103.24 | $113.50 |
Enterprise Value | $93.86B | $330.27B |
Dividend Yield | 1.15% | 3.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson Controls International PLC
Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration systems, and fire and security solutions. Commercial HVAC accounts for about 40% of sales, fire and security also represents 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 20% of revenue. In fiscal 2021, Johnson Controls generated over $23.5 billion in revenue.
Read more on JCI →About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →
